Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harold Kim
David Fischer

Showing results (271-280 of 311) with videos related to

Pageof 32
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2014
Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicityPhuc Felix Nguyen-Tan, Qiang Zhang, K Kian Ang, et al.
Journal of Clinical Medicine|June 26, 2025
Worthwhile or Not? The Pain-Gain Ratio of Screening Routine cMRIs in a Maximum Care University Hospital for Incidental Intracranial Aneurysms Using Artificial IntelligenceFranziska Mueller, Christina Carina Schmidt, Robert Stahl, et al.
Protein Expression and Purification|June 14, 2011
Affinity purification of a chimeric nicotinic acetylcholine receptor in the agonist and antagonist bound statesShenping Liu, Merrill S Babcock, Jacob Bode, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 20, 2018
Targeted exome analysis identifies the genetic basis of disease in over 50% of patients with a wide range of ataxia-related phenotypesMiao Sun, Amy Knight Johnson, Viswateja Nelakuditi, et al.
Oral Oncology|February 28, 2021
Risk groups of laryngeal cancer treated with chemoradiation according to nomogram scores - A pooled analysis of RTOG 0129 and 0522Musaddiq J Awan, Haley Gittleman, Jill Barnholtz-Sloan, et al.
Cancer|July 16, 2016
Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234)Vasu Divi, Jonathan Harris, Paul M Harari, et al.
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202Colleen A F Lawton, Xiaolei Lin, Gerald E Hanks, et al.
Neurology. Clinical Practice|August 26, 2024
The Recovery of Consciousness via Evidence-Based Medicine and Research (RECOVER) Program: A Paradigm for Advancing NeuroprognosticationDavid Fischer, Benjamin S Abella, Geoffrey D Bass, et al.
Biochemical and Biophysical Research Communications|May 4, 2010
Expression, purification, and characterization of TYK-2 kinase domain, a member of the Janus kinase familyBrian Korniski, Arthur J Wittwer, Thomas L Emmons, et al.
International Journal of Radiation Oncology, Biology, Physics|July 26, 2015
A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902Seth A Rosenthal, Daniel Hunt, A Oliver Sartor, et al.
Pageof 32

Showing results (271-280 of 311) with videos related to

Sort By:
Pageof 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2014
Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicityPhuc Felix Nguyen-Tan, Qiang Zhang, K Kian Ang, et al.
Journal of Clinical Medicine|June 26, 2025
Worthwhile or Not? The Pain-Gain Ratio of Screening Routine cMRIs in a Maximum Care University Hospital for Incidental Intracranial Aneurysms Using Artificial IntelligenceFranziska Mueller, Christina Carina Schmidt, Robert Stahl, et al.
Protein Expression and Purification|June 14, 2011
Affinity purification of a chimeric nicotinic acetylcholine receptor in the agonist and antagonist bound statesShenping Liu, Merrill S Babcock, Jacob Bode, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 20, 2018
Targeted exome analysis identifies the genetic basis of disease in over 50% of patients with a wide range of ataxia-related phenotypesMiao Sun, Amy Knight Johnson, Viswateja Nelakuditi, et al.
Oral Oncology|February 28, 2021
Risk groups of laryngeal cancer treated with chemoradiation according to nomogram scores - A pooled analysis of RTOG 0129 and 0522Musaddiq J Awan, Haley Gittleman, Jill Barnholtz-Sloan, et al.
Cancer|July 16, 2016
Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234)Vasu Divi, Jonathan Harris, Paul M Harari, et al.
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202Colleen A F Lawton, Xiaolei Lin, Gerald E Hanks, et al.
Neurology. Clinical Practice|August 26, 2024
The Recovery of Consciousness via Evidence-Based Medicine and Research (RECOVER) Program: A Paradigm for Advancing NeuroprognosticationDavid Fischer, Benjamin S Abella, Geoffrey D Bass, et al.
Biochemical and Biophysical Research Communications|May 4, 2010
Expression, purification, and characterization of TYK-2 kinase domain, a member of the Janus kinase familyBrian Korniski, Arthur J Wittwer, Thomas L Emmons, et al.
International Journal of Radiation Oncology, Biology, Physics|July 26, 2015
A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902Seth A Rosenthal, Daniel Hunt, A Oliver Sartor, et al.
Pageof 32